Event Type
Disclosure
Mandatory
Variant
8-K
Results of Operations and Financial Condition. On January 12, 2026, USANA Health Sciences, Inc. (the “Company” or “USANA”) issued a press release announcing pre
Regulation FD Disclosure On January 12, 2026, the Company issued a press release announcing preliminary net sales for the fiscal year ended January 3, 2026 alon
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press release issued by USANA Health Sciences, Inc. dated January 12, 2026 (furnish